MLSS— MILESTONE SCIENTIFIC INC.

Health Care$42M mkt cap

Metric	FY2025	FY2024	FY2023	FY2022
Product sales, net	$9.0M+4.0%	$8.6M-12.2%	$9.8M+11.6%	$8.8M
Cost of products sold	$2.6M+16.9%	$2.2M-27.7%	$3.0M-22.3%	$3.9M
Gross profit	$6.4M-0.4%	$6.4M-5.3%	$6.8M+38.6%	$4.9M
Selling, general and administrative expenses	$11.6M-5.8%	$12.3M-6.4%	$13.1M+5.0%	$12.5M
Research and development expenses	$449K-47.7%	$859K+22.4%	$701K-39.0%	$1.2M
Depreciation and amortization expense	$78K+108.8%	$37K-39.5%	$62K-2.9%	$64K
Total operating expenses	$12.1M-8.2%	$13.2M-5.1%	$13.9M+1.2%	$13.7M
Loss from operations	-$5.7M+15.7%	-$6.8M+4.9%	-$7.1M+19.5%	-$8.8M
Interest (expense) income, net	-$26K-142.5%	$60K	—	—
Gain on sale of net operating losses	$2.0M	—	$0	—
Loss before provision for income taxes	-$5.7M-21.4%	-$4.7M+32.5%	-$7.0M+20.4%	-$8.8M
Provision for income taxes	—	—	—	$0
Net loss	-$5.7M-21.4%	-$4.7M+32.5%	-$7.0M+20.4%	-$8.8M
Net loss per share applicable to common stockholders - basic	-$0.07-16.7%	-$0.06+40.0%	-$0.10+16.7%	-$0.12
Net loss per share applicable to common stockholders - diluted	-$0.07-16.7%	-$0.06	—	—
Weighted average shares outstanding and to be issued - basic	82.1M+2.8%	79.8M+9.6%	72.8M+3.1%	70.6M
Weighted average shares outstanding and to be issued - diluted	82.1M+2.8%	79.8M	—	—

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 12 more years of annual history and full quarterly detail on Pro.

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.